Sheffield Local Optometric Committee

Ocular adverse effects with Bisphosphonate

The following was taken from an article by Ian Hutchison, Clinical practice pharmacist at SY&B clinical support unit

There appears to be a link between bisphosphonate use and an increased risk of UVEITIS and SCLERITIS.
Bisphosphonates are used for treatment and prevention of Osteoporosis. In most cases the condition developed rapidly following initiation of therapy.

The oral bisphosphonate medicines prescribed in the UK are:

alendronate (brand names Fosamax, Fosamax Once Weekly, Fosavance) sodium clodronate (Bonefos, Loron) disodium etidronate (Didronel, Didronel PMO) ibandronate (Bondronat, Bonviva) risedronate sodium (Actonel, Actonel Once a Week) disodium tiludronate (Skelid)

Next Meeting:

Copthorne hotel,
Bramall La.,

at 7.30pm Tuesday 26th June 2018

Mailing List

Join our mailing list